A. Enteral administration groups | |||||
 | Control | E-LF 7.5m | E-LF 15m | E-LF 30m | E-LF 60m |
Number (n) | 8 | 8 | 8 | 8 | 8 |
LV dP/dt max (mmHg/s) | 2500 ± 213 | 2556 ± 253 | 2608 ± 271 | 2669 ± 321 | 2391 ± 147 |
Heart rate (bpm) | 236 ± 25 | 234 ± 24 | 226 ± 21 | 244 ± 18 | 255 ± 42 |
Coronary flow (mL/min) | 14.1 ± 1.3 | 13.3 ± 0.7 | 14.4 ± 0.9 | 14.0 ± 1.7 | 13.0 ± 1.5 |
B. Parenteral administration groups | |||||
 | Control | P-LF 15 | P-LF 100 | ||
Number (n) | 8 | 8 | 8 | ||
LV dP/dt max (mmHg/s) | 2583 ± 374 | 2546 ± 420 | 2569 ± 289 | ||
Heart rate (bpm) | 270 ± 42 | 256 ± 52 | 246 ± 29 | ||
Coronary flow (mL/min) | 15.7 ± 1.8 | 14.4 ± 0.9 | 14.7 ± 1.7 |